Indegene has incorporated a step-down wholly owned subsidiary (WOS) by name Indegene Portugal, Unipessoal LDA, on October 23, 2026. Indegene Ireland, a wholly owned subsidiary of the company, holds 100% of the share capital of Indegene Portugal, Unipessoal LDA.
The step-down subsidiary will provide services for the life sciences, healthcare, and biopharmaceutical sectors; Corporate services for other affiliated entities; Content development and technology support services; Support services related to clinical development and medical affairs; Support services related to medical education and communications.
Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products.
